![Isaac Kobrin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Isaac Kobrin
Fondateur chez TOLREMO therapeutics AG
Provenance du réseau au premier degré de Isaac Kobrin
Entité | Type d'entité | Industrie | |
---|---|---|---|
F. Hoffmann-La Roche Ltd.
![]() F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.
31
| Subsidiary | Pharmaceuticals: Major | 31 |
22
| Extinct | Pharmaceuticals: Major | 22 |
Novaremed AG
![]() Novaremed AG Pharmaceuticals: MajorHealth Technology Novaremed AG operates as a pharmaceutical company. It develops NEB74S, a molecule for the treatment of chronic pain. The company was founded by Eliahu Kaplan in 2008 and is headquartered in Petah Tikva, Israel.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Private Company | Pharmaceuticals: Major | 10 | |
TOLREMO therapeutics AG
![]() TOLREMO therapeutics AG Miscellaneous Commercial ServicesCommercial Services TOLREMO therapeutics AG engages in discovering and developing therapies for treating cancer patients. The firm serves on academic research laboratories, flourishing life sciences spin-offs and cutting-edge technology platforms. The company was founded by Stefanie Flückiger-Mangual, Wilhelm Krek, Karl-Heinz Altmann, Isaac Kobrin, and Emmanuel Savioz in March 2017 and is headquartered in Zurich, Switzerland.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Isaac Kobrin via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
ROCHE HOLDING AG | Pharmaceuticals: Major | Chairman General Counsel Corporate Officer/Principal Chairman | |
Schering-Plough Corp.
![]() Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
VERNALIS | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
MedGenesis Therapeutix, Inc.
![]() MedGenesis Therapeutix, Inc. Medical SpecialtiesHealth Technology MedGenesis Therapeutix, Inc. provides diagnostic product services. The private company is based in Victoria, Canada. The Canadian company was founded by Erich Mohr, Howard J. Federoff. Erich Mohr has been the CEO since incorporation. | Medical Specialties | Director/Board Member Director/Board Member | |
Gen-Probe, Inc.
![]() Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Chairman Compliance Officer | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Pierre Fabre SA
![]() Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Human Resources Officer | |
Roche Group
![]() Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Chief Executive Officer Compliance Officer Chief Executive Officer | |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Miscellaneous Commercial Services | Director/Board Member Chairman Corporate Officer/Principal | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Founder Director/Board Member | |
INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
University of St. Gallen | College/University | Doctorate Degree Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Founder Chairman Chief Tech/Sci/R&D Officer | |
TeGenero AG
![]() TeGenero AG Pharmaceuticals: MajorHealth Technology TeGenero AG discovers and develops novel therapeutics. It is a biopharmaceutical company providing services in the identification and development of effective and applicable therapeutics for the treatment of severe immunological disorders. It's first development candidate TGN1412, a SuperMAB with specificity for the T cell surface receptor CD28 is in non-clinical development. Clinical applications of SuperMAB and its derived compounds are expected to solve unmet medical needs in the fields of cancer-related immunodeficiencies such as B-cell chronic lymphocytic leukaemia and autoimmune/inflammatory diseases like rheumatoid arthritis. The company was founded in 2000 and is headquartered in Wurzburg, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Undergraduate Degree Doctorate Degree | |
University of Basel | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of Zurich | College/University | Doctorate Degree Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
University of Bern | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
ABIONYX PHARMA | Pharmaceuticals: Major | Chairman Chairman | |
École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
The Biotechnology Institute
![]() The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
![]() European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
Roche (Brussels) | Director of Finance/CFO Director of Finance/CFO | ||
Roche Deutschland Holding GmbH
![]() Roche Deutschland Holding GmbH Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Roche Deutschland Holding GmbH is a German company that manufactures and distributes pharmaceutical products. The company is based in Grenzach-Wyhlen, Germany. The company was founded in 1997 by Fritz Hoffmann-La Roche. The CEO is Claudia Fleischer. Roche Deutschland Holding was acquired by NEXUS AG on November 30, 2018. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Roche Pharma AG
![]() Roche Pharma AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma AG is a world leader in innovative cancer drugs and has brought many highly effective drugs onto the market. The company is based in Grenzach-Wyhlen, Germany. The German company also focuses on viral infections, metabolic, central nervous system disorders, and inflammatory diseases. Roche Diagnostics, a subsidiary of Roche Pharma, develops diagnostic tests, instruments, and digital solutions to transform healthcare globally. Roche has been committed to improving lives since its founding in 1896 and creates innovative medicines and diagnostic tests that help millions of patients worldwide. | Medical Distributors | Director/Board Member Chairman | |
Humer Foundation | Chairman Director/Board Member | ||
GEFEN BIOMED INVESTMENTS LTD | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
Harvard Business School | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
Amal Therapeutics SA
![]() Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland. | Biotechnology | Director/Board Member Director/Board Member | |
Ventaleon GmbH
![]() Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Ventaleon GmbH is a biotechnology company, which engages in the development of inhaled treatments against viral infections. Its products include LASAG (D,L-lysine acetylsalicylate • glycine), a lysin-salt formulation of well known acetyl salicylic acid. The company was founded by Gerhard Scheuch in 2012 and is headquartered in Gauting, Germany. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Anokion SA
![]() Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Actelion Pharmaceuticals Korea Ltd.
![]() Actelion Pharmaceuticals Korea Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Korea Ltd. is a South Korean pharmaceutical company that manufactures pharmaceutical products. The company is based in Seoul, South Korea. The company was founded in 1983. The CEO is Jenny Jeong. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Actelion Pharmaceuticals Ltd.
![]() Actelion Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals Ltd. is a Swiss company that develops and distributes molecular weight drugs. The company is based in Allschwil, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO | |
IDORSIA LTD | Pharmaceuticals: Major | Chairman Chairman Chief Tech/Sci/R&D Officer General Counsel Human Resources Officer | |
Idorsia Pharmaceuticals Ltd.
![]() Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a Swiss company that aims to discover, develop, and provide innovative medicines to patients. The company is based in Allschwil, Switzerland. The company has created an eBook that provides useful information about Fabry disease, a rare inherited disorder caused by the build-up of a fat-like substance in the cells of the body organs. Jean-Paul Clozel has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Arvelle Therapeutics International GmbH
![]() Arvelle Therapeutics International GmbH BiotechnologyHealth Technology Arvelle Therapeutics GmbH provides treatment for patients suffering form CNS disorders. The company was founded by Ilise Lombrado, Gregory Mark Weinhoff and Mark Altmeyer and is headquartered in Basel, Switzerland. | Biotechnology | Founder Chairman |
Statistiques
Internationale
Suisse | 19 |
Etats-Unis | 11 |
Allemagne | 10 |
France | 5 |
Royaume-Uni | 3 |
Sectorielle
Health Technology | 28 |
Consumer Services | 11 |
Commercial Services | 6 |
Finance | 4 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 395 |
Corporate Officer/Principal | 165 |
Chairman | 122 |
Independent Dir/Board Member | 72 |
Chief Executive Officer | 61 |
Relations les plus connectées
Insiders | |
---|---|
Franz Humer | 45 |
Jean-Luc Bélingard | 40 |
Erich Maximilian Platzer | 31 |
Jean-Pierre Garnier | 28 |
Leonard Patrick Gage | 26 |
Gottlieb A. Keller | 26 |
Elias Zerhouni | 26 |
Joseph Scodari | 24 |
Severin Schwan | 23 |
Pamela Kirby | 22 |
Harry Welten | 22 |
Karin Hehenberger | 21 |
Richard T. Laube | 21 |
Herbert Conrad | 21 |
René Lerer | 20 |
- Bourse
- Insiders
- Isaac Kobrin
- Connexions Sociétés